Methyldopa and Hydrochlorothiazide
- Product NDC
- 0378-0507
- 11-digit product format
- 003780507
- Labeler code
- 0378
- Product ID
- 0378-0507_4e3df2ee-0756-4820-baa3-354d588d447c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methyldopa and hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- ANDA070265
- Marketing category
- ANDA
- Marketing start
- 1986-01-23
- Marketing end
- 0000-00-00
- Substance
- METHYLDOPA; HYDROCHLOROTHIAZIDE
- Active strength
- 250 mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0378-0507-01 | 00378050701 | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0507-01) | 100 tablet | 1986-01-23 | 0000-00-00 | No | No | Current |